LENSAR (NASDAQ:LNSR) Posts Earnings Results, Misses Expectations By $1.40 EPS

LENSAR (NASDAQ:LNSR) issued its quarterly earnings results on Thursday. The company reported ($1.61) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($1.40), Zacks reports. LENSAR had a negative return on equity of 49.02% and a negative net margin of 34.03%. The company had revenue of $16.73 million for the quarter, compared to analysts’ expectations of $14.95 million. LENSAR updated its FY 2025 guidance to EPS and its Q1 2025 guidance to EPS.

LENSAR Trading Up 12.1 %

Shares of LNSR stock traded up $1.31 during trading hours on Friday, hitting $12.18. 139,808 shares of the company’s stock were exchanged, compared to its average volume of 92,765. LENSAR has a 12-month low of $2.67 and a 12-month high of $13.03. The company has a market capitalization of $141.47 million, a PE ratio of -8.34 and a beta of 0.66. The business’s 50 day simple moving average is $9.47 and its 200-day simple moving average is $6.99.

Wall Street Analyst Weigh In

Separately, Lake Street Capital lifted their target price on LENSAR from $12.00 to $16.00 and gave the company a “buy” rating in a report on Friday.

About LENSAR

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.